BD
Biodesix, Inc.
BDSX · NASDAQ
$26.63 +2.54% (+$0.66)
1M +7.12%
Market Cap $216.8M
P/E Ratio -
Div. Yield -
ROE 788.19%
Bulios Fair Price
$38.65
45.1% upside
Current Price
$26.63
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BDSX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
37 /100
Fair P/B 23.71x
P/S 2.11x
EV/EBITDA N/A
Growth
100 /100
Growing Rev. growth 32.31%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 26.97%
Op. margin 20.01%
FCF margin 19.82%
Quality
14 /100
Poor ROE 788.19%
ROA 29.12%
Asset turnover 1.08x
Debt
23 /100
High Current ratio 2.85x
Int. coverage -2.45x
Debt/Equity 7.85x
Stability
80 /100
Stable Rev. volatility 11.20%
EPS volatility 14.96%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BDSX
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Scott Hutton
Employees
334
Headquarters
Louisville
Upcoming events
02 NOV
Earnings
Upcoming earnings report